O. Petteri Hirvonen
Petteri Hirvonen is the CEO and CSO of Replicon Health Ltd. He has operations responsibility in business development, financial planning, mathematical modelling and statistical analyses. Petteri has more than 20 years of significant experience in demanding strategic, economic and statistical analyses, valuations and investment management.
In Autumn 2018, Petteri Hirvonen joined a PhD program in exercise physiology. This new activity is a continuum of long lasting scientific relation with the professors. Future research and scientific publications serve Mr. Hirvonen’ role as the CSO of Replicon Health Ltd.
During the last 15 to 20 years Mr. Hirvonen have actively led numerous business development, strategy and financing projects in Cleantech and Life Science -sector companies. Earlier his has acted as investment director, financial analyst and chief economist in many leading companies in Finland. During his 25 year career he has acquired deep understanding of reduced/smart mathematical modelling of ultra-complicated systems ( econometrics / biometrics), valuations, economics and molecular physiology of energy metabolism.
Prior to starting as a fulltime employee in Replicon in 2003 Petteri Hirvonen was a Senior Partner and Chief Investment Officer at Mandatum Asset Management as well as the Chief Economist of Mandatum Bank. Before joining Mandatum, Mr. Hirvonen was affiliated with DavyProtos Ltd, Finnish Export Credit (1 billion euro of stocks and bonds under management) and Kansallis Bank in various positions of investing, financing, and research operations. During late 1980’s Mr. Hirvonen acted as a researcher in the Research Institute of Finnish Economy (ETLA).
Before his work-life Petteri Hirvonen graduated from the University of Helsinki in 1988 (MSc(Econ)). He started his university studies in Law School and he has also completed studies in Mathematical faculty of the University of Helsinki. Mr. Hirvonen has lectured several university level courses in statistics. Additionally, in 2003 he received an MBA degree from Helsinki School of Economics with two majors: Finance and Biotech Management.